Poniard Pharmaceuticals, Inc.
PARD · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,051 | -$45,715 | -$48,565 | -$32,782 |
| Dep. & Amort. | $1,313 | $1,470 | $1,603 | $1,134 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,909 | $7,293 | $7,123 | $0 |
| Change in WC | -$6,937 | -$2,508 | $5,973 | $1,631 |
| Other Non-Cash | $2,490 | $3,969 | $379 | $5,364 |
| Operating Cash Flow | -$24,276 | -$35,491 | -$33,487 | -$24,653 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$21 | -$391 | -$5,773 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7,322 | -$52,607 | -$46,277 | -$104,058 |
| Inv. Sales/Matur. | $31,296 | $53,676 | $80,950 | $51,560 |
| Other Inv. Act. | $58 | $112 | $0 | $2,729 |
| Investing Cash Flow | $24,025 | $1,160 | $34,282 | -$55,542 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$20,426 | -$7,918 | $14,423 | -$3,941 |
| Stock Issued | $6,092 | $14,543 | $0 | $69,968 |
| Stock Repurch. | -$192 | -$500 | -$500 | $0 |
| Dividends Paid | $0 | -$500 | -$500 | -$500 |
| Other Fin. Act. | -$69 | $320 | -$409 | -$145 |
| Financing Cash Flow | -$14,403 | $6,125 | $14,014 | $65,382 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,654 | -$28,206 | $14,809 | -$14,813 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,938 | $44,144 | $29,335 | $44,148 |
| End Cash | $1,284 | $15,938 | $44,144 | $29,335 |
| Free Cash Flow | -$24,283 | -$35,512 | -$33,878 | -$30,426 |